Inventor
DELLAMARY LUIS A
US73 patents
⚠️ This page may combine multiple inventors who share the name “DELLAMARY LUIS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OTONOMY INC
11 patentsUS8030297B2Oct 4, 2011
Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
OTONOMY INC73 citations99
US8349353B2Jan 8, 2013
Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
OTONOMY INC21 citations92
US10272034B2Apr 30, 2019
Auris formulations for treating otic diseases and conditions
OTONOMY INC7 citations84
US9744126B2Aug 29, 2017
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
OTONOMY INC3 citations84
US9603796B2Mar 28, 2017
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
OTONOMY INC3 citations84
US9486405B2Nov 8, 2016
Methods for the treatment of pediatric otic disorders
OTONOMY INC7 citations84
US9427472B2Aug 30, 2016
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
OTONOMY INC13 citations84
US9333171B2May 10, 2016
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
OTONOMY INC7 citations84
US9066855B2Jun 30, 2015
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
OTONOMY INC5 citations84
US9205048B2Dec 8, 2015
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
OTONOMY INC3 citations74
US10772828B2Sep 15, 2020
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
OTONOMY INC1 citations73
LICHTER JAY
11 patentsUS8318817B2Nov 27, 2012
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
LICHTER JAY38 citations96
US9132087B2Sep 15, 2015
Auris formulations for treating otic diseases and conditions
LICHTER JAY30 citations94
US8784870B2Jul 22, 2014
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
LICHTER JAY35 citations94
US8399018B2Mar 19, 2013
Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
LICHTER JAY49 citations94
US8846770B2Sep 30, 2014
Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
LICHTER JAY33 citations93
US8648119B2Feb 11, 2014
Controlled release immunomodulator compositions and methods for the treatment of otic disorders
LICHTER JAY23 citations92
US8496957B2Jul 30, 2013
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
LICHTER JAY29 citations92
US10092580B2Oct 9, 2018
Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
LICHTER JAY8 citations84
US8852626B2Oct 7, 2014
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
LICHTER JAY10 citations84
US8828980B2Sep 9, 2014
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
LICHTER JAY7 citations84
US8658626B2Feb 25, 2014
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
LICHTER JAY4 citations84
NEKTAR THERAPEUTICS
5 patentsUS7306787B2Dec 11, 2007
Engineered particles and methods of use
NEKTAR THERAPEUTICS137 citations99
US6946117B1Sep 20, 2005
Stabilized preparations for use in nebulizers
NEKTAR THERAPEUTICS94 citations98
US6638495B2Oct 28, 2003
Stabilized preparation for use in metered dose inhalers
NEKTAR THERAPEUTICS66 citations96
US6630169B1Oct 7, 2003
Particulate delivery systems and methods of use
NEKTAR THERAPEUTICS163 citations96
US7393544B2Jul 1, 2008
Dispersion for pulmonary delivery of a bioactive agent
NEKTAR THERAPEUTICS28 citations93
ALLIANCE PHARMA
4 patentsUS5733526AMar 31, 1998
Hydrocarbon oil/fluorochemical preparations and methods of use
ALLIANCE PHARMA171 citations98
US5874481AFeb 23, 1999
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
ALLIANCE PHARMA263 citations97
US5667809ASep 16, 1997
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
ALLIANCE PHARMA147 citations97
US6280745B1Aug 28, 2001
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
ALLIANCE PHARMA59 citations95
INHALE THERAPEUTIC SYST
3 patentsUS6565885B1May 20, 2003
Methods of spray drying pharmaceutical compositions
INHALE THERAPEUTIC SYST324 citations99
US6433040B1Aug 13, 2002
Stabilized bioactive preparations and methods of use
INHALE THERAPEUTIC SYST126 citations99
US6309623B1Oct 30, 2001
Stabilized preparations for use in metered dose inhalers
INHALE THERAPEUTIC SYST267 citations99
WEERS JEFFRY G
3 patentsUS7442388B2Oct 28, 2008
Phospholipid-based powders for drug delivery
WEERS JEFFRY G54 citations96
US9439862B2Sep 13, 2016
Phospholipid-based powders for drug delivery
WEERS JEFFRY G15 citations92
US8246934B2Aug 21, 2012
Respiratory dispersion for metered dose inhalers comprising perforated microstructures
WEERS JEFFRY G16 citations92
NOVARTIS AG
3 patentsUS7790145B2Sep 7, 2010
Respiratory dispersion for metered dose inhalers
NOVARTIS AG25 citations93
US8349294B2Jan 8, 2013
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
NOVARTIS AG6 citations84
US7871598B1Jan 18, 2011
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
NOVARTIS AG10 citations84
DELLAMARY LUIS A
2 patentsENDEAVOR BIOMEDICINES INC
2 patentsSAMUMED LLC
2 patentsTARARA THOMAS E
1 patentBIOSPLICE THERAPEUTICS INC
1 patentUNIV CALIFORNIA
1 patentYE QIANG
1 patentShowing the top 50 of 73 patents by PatentIndex Score.